Ascentage Pharma Group Intl ADR (AAPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 172,785 | 150,516 | N/A |
| Receivables | 11,390 | 20,076 | N/A |
| Inventories | 904 | 2,225 | N/A |
| TOTAL | $201,959 | $184,965 | $N/A |
| Non-Current Assets | |||
| PPE Net | 116,374 | 124,644 | N/A |
| Investments And Advances | 4,638 | 2,607 | 0 |
| Intangibles | 13,795 | 15,156 | 0 |
| Other Non-Current Assets | 21,872 | 16,693 | 0 |
| TOTAL | $156,679 | $159,100 | $N/A |
| Total Assets | $358,638 | $344,065 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 106,731 | 84,820 | N/A |
| Accounts payable and accrued liabilities | 47,959 | 38,441 | 0 |
| Other current liabilities | 5,135 | 5,285 | N/A |
| TOTAL | $159,825 | $128,546 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 121,852 | 162,262 | N/A |
| Other Non-Current Liabilities | 34,933 | 37,093 | 0 |
| TOTAL | $161,253 | $205,800 | $N/A |
| Total Liabilities | $321,078 | $334,346 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 29 | 27 | N/A |
| Retained earnings | -790,563 | -738,265 | N/A |
| Other shareholders' equity | -15,907 | -16,837 | 0 |
| TOTAL | $37,560 | $9,719 | $N/A |
| Total Liabilities And Equity | $358,638 | $344,065 | $0 |